Presentation
13 March 2024 Near-infrared II photobiomodulation to treat cardiovascular diseases via restoring endothelial nitric oxide bioavailability
Author Affiliations +
Abstract
Photobiomodulation (PBM) with low-power near-infrared (NIR) light has shown diverse beneficial effects. Recent studies report that PBM also increases bioavailable nitric oxide (NO), which is a critical gaseous mediator for various physiological processes and could be used to treat cardiovascular and cerebrovascular diseases with suppressed endothelial NO production. We explored using NIR-II light (1000-1700 nm) for PBM. NIR-II laser treatment efficiently enhanced NO generation in endothelial cells. Since impaired NO production is also associated with neurological diseases, this novel therapy could be further explored to treat diseases such as traumatic brain injury, sleep disorders, and Alzheimer's disease.
Conference Presentation
© (2024) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Shinya Yokomizo, Denis E. Bragin, Dmitry Gerashchenko, Dmitriy N. Atochin, and Satoshi Kashiwagi "Near-infrared II photobiomodulation to treat cardiovascular diseases via restoring endothelial nitric oxide bioavailability", Proc. SPIE PC12826, Mechanisms of Photobiomodulation Therapy XVIII, PC1282604 (13 March 2024); https://doi.org/10.1117/12.3003398
Advertisement
Advertisement
KEYWORDS
NOx

Cardiovascular disorders

Laser therapeutics

Mitochondria

Cerebrovascular diseases

Near infrared

Light scattering

Back to Top